15th Nov 2024 Quality of life in CheckMate 9ER: cabozantinib and nivolumab for advanced renal cell carcinoma
16th Sep 2024 Plain language summary of the NefIgArd trial: Nefecon for treating patients with immunoglobulin A nephropathy